Factors Affecting the Serum Cotinine Level of Male Smokers in Malang, Indonesia
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 13 No. 3 (2023),
17 October 2023
,
Page 40130
https://doi.org/10.32598/ijmtfm.v13i3.40130
Abstract
Background: In tobacco, nicotine is the primary toxic agent that causes health problems. As a primary metabolite of nicotine, cotinine is frequently used as an accurate measure of exposure to tobacco smoke. This study aims to find the factors affecting the serum cotinine level of male smokers in Malang, Indonesia.
Methods: This cross-sectional study was conducted on 183 men who smoke regularly in Malang, Indonesia. They were selected by a purposive sampling method. Nicotine dependency and cotinine level were measured using the Fagerstrom test for nicotine dependence and the human cotinine ELISA Kit, respectively. Multiple linear regression analysis was performed to determine the effect of age, smoking duration, cigarette type, and the nicotine dependence on the continue level. ANOVA and independent t-test were also used for testing the study hypothesis. The significance level was set at 0.05.
Results: Based on the ANOVA results, the factors of age, smoking duration, type of cigarette, and nicotine dependence together had a significant effect on the cotinine level (P<0.001). Based on the independent t-test results, only the age factor had a significant effect on the cotinine level (P<0.001).
Conclusion: Older male smokers may have higher cotinine level. Other factors including duration of smoking, type of cigarette, and nicotine dependence have no significant effect on cotinine level of male smokers.
- smoking
- cotinine
- nicotine
- addiction
- risk behaviour
- aging
- 09/30/2023 (2)
- 09/23/2023 (1)
How to Cite
References
World Health Organization. Noncommunicable diseases. Geneva: World Health Organization; 2022. [Link]
Karimi J, Maghsoudi M, Shojaei AL, Yazdani S, Mohammadian Khonsari N, Bahmani K, et al. Assessment of risk factors and the effect of drug abuse on the incidence of ischemic heart disease in patients less than 40 years old. International Journal of Medical Toxicology and Forensic Medicine. 2021; 11(1):31751. [DOI:10.32598/ijmtfm.v11i1.31751]
Brunssen C, Giebe S, Hofmann A, Brux M, Morawietz H. Evaluation of cytotoxic oxidative and pro-inflammatory effects of aqueous cigarette smoke extract on human monocytes: A potential model system for assessment of next-generation tobacco and nicotine products. Applied In Vitro Toxicology. 2017; 3(1). [DOI:10.1089/aivt.2016.0037]
Siegel RL, Miller KD, Jemal A. Cancer statistics 2018. CA: A Cancer Journal for Clinicians. 2018; 68(1):7-30. [DOI:10.3322/caac.21442] [PMID]
Reitsma MB, Flor LS, Mullany EC, Gupta V, Hay SI, Gakidou E. Spatial temporal and demographic patterns in the prevalence of smoking tobacco use and initiation among young people in 204 countries and territories 1990 - 2019. The Lancet Public Health. 2019; 6(7):e472-81. [DOI:10.1016/S2468-2667(21)00102-X] [PMID]
Thirumalai DT. Cigarette smoke-induced oxidative stress: A systematic review. B R Nahata Smriti Sansthan International Journal of Phramaceutical Sciences & Clinical Research. 2021; 1(2):95-9 [DOI:10.22377/ijpscr.v1i2.15]
Soleimani F, Dobaradaran S, De-la-Torre GE, Schmidt TC, Saeedi R. Content of toxic components of cigarette cigarette smoke vs cigarette butts: A comprehensive systematic review. Science of The Total Environment. 2022; 813:152667. [PMID]
Dani J. Kosten T. R. Benowitz N. L. The pharmacology of nicotine and tobacco. In: Miller SC Fiellin DA Rosenthal RN, editors. The ASAM principles of addiction medicine. Philadelphia: Wolters Kluwer; 2019. [Link]
Benowitz NL. Clinical pharmacology of nicotine: Implications for understanding preventing and treating tobacco addiction. Clinical Pharmacology and Therapeutics. 2008; 83(4):531-41. [DOI:10.1038/clpt.2008.3] [PMID]
Emmons KM, Abrams DB, Marshall R, Marcus BH, Kane M, Novotny TE, et al. An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Preventive Medicine. 1994; 23(1):35-9. [DOI:10.1006/pmed.1994.1005] [PMID]
Wolvers PJD, Bruin SC, Mairuhu WM, de Leeuw-Terwijn M, Hutten BA, Brandjes DPM, et al. Self-Reported smoking compared to serum cotinine in bariatric surgery patients: Smoking is underreported before the operation. Obesity Surgery. 2020; 30(1):23-37. [DOI:10.1007/s11695-019-04128-4] [PMID]
St Charles FK, Cook CJ, Clayton PM. The linear relationship between cigarette tar and nicotine yields: Regulatory implications for smoke constituent ratios. Regulatory Toxicology and Pharmacology. 2011; 59(1):143-8. [DOI:10.1016/j.yrtph.2011.01.001] [PMID]
McGrath-Morrow SA, Gorzkowski J, Groner JA, Rule AM, Wilson K, Tanski SE, et al. The effects of nicotine on development. Pediatrics. 2020; 145(3):e20191346. [DOI:10.1542/peds.2019-1346] [PMID] [PMCID]
Hartmann-Boyce J, Begh R, Aveyard P. Electronic cigarettes for smoking cessation. BMJ. 2018; 360:j5543. [DOI:10.1136/bmj.j5543] [PMID]
Park MB, Choi JK. Differences between the effects of conventional cigarettes, e-cigarettes and dual product use on urine cotinine levels. Tobacco Induced Diseases. 2019; 17:12. [PMID]
Molander L, Hansson A, Lunell E. Pharmacokinetics of nicotine in healthy elderly people. Clinical Pharmacology & Therapeutics, 2001; 69(1):57-65. [DOI:10.1067/mcp.2001.113181] [PMID]
American Association of Respiratory Care (AARC). The Fagerstrom test for nicotine dependence. Irving: American Association of Respiratory Care; 2022. [Link]
Banafshe HReza, Ghaderi A. Thallium intoxication in relation to drug abuse and cigarette smoking in Iran. International Journal of Medical Toxicology and Forensic Medicine. 2018; 8(2): 41-4. [DOI:10.22037/ijmtfm.v0i0.22090]
Shrestha S, Mishra DR, Dhakal N, Bhandari S, Khanal S, Lamsal M. Correlation of urinary cotinine with cardiovascular risk factors in pan masala tobacco users. Indian Heart Journal. 2019; 71(6):459-63. [DOI:10.1016/j.ihj.2019.10.001] [PMID] [PMCID]
Upadhyay A, Mishra A, Chaudhury S, Chattopadhyay P. Mitochondrial anti-oxidant enzymes caused by cigarette smoke in experimental wistar rat. Research Journal of Pharmacy and Technology. 2009; 2(4):690-3. [Link]
Benowitz NL, Jacob P, Fong I, Gupta S. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine.The Journal of Pharmacology and Experimental Therapeutics. 1994; 268(1):296-303. [Link]
Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environmental Health Perspectives. 1999; 107 Suppl 2(Suppl 2):349-55. [DOI:10.1289/ehp.99107s2349] [PMID] [PMCID]
Ogden MW, Maiolo KC, Nelson PR, Heavner DL, Green CR. Artefacts in determining the vapour-particulate phase distribution of environmental tobacco smoke nicotine. Environmental Technology. 1993; 14(8):779-85. [DOI:10.1080/09593339309385349]
Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews. 1996; 18(2):188-204. [DOI:10.1093/oxfordjournals.epirev.a017925] [PMID]
Benowitz NL, Jacob P 3rd. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology Therapeutics. 1994; 56(5) 483-493. [DOI:https://doi.org/10.1038/clpt.1994.169] [PMID]
Terry AV Jr, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ. Cotinine a neuroactive metabolite of nicotine: Potential for treating disorders of impaired cognition. CNS Drug Reviews. 2005; 11(3):229-52. [DOI:10.1111/j.1527-3458.2005.tb00045.x] [PMID] [PMCID]
Vlăsceanu AM, Petraru C, Baconi D, Ghica M, Arsene A, Popa L, et al. Quantitative relationships of urinary cotinine levels in smoking diabetic patients. Farmacia. 2015; 63(3):349-56. [Link]
Vlasceanu AM, Chirita C, Mihai D, Marineci CD, Stan M, Balalau C, et al. Comparative study on the psychoactive effects of nicotine and cotinine. Revista de Chimie. 2019; 70(4):1114-7. [DOI:10.37358/RC.19.4.7075]
Kumboyono K, Chomsy IN, Hakim AK, Sujuti H, Hariyanti T, Srihardyastutie A, et al. Detection of vascular inflammation and oxidative stress by cotinine in smokers: Measured through interleukin-6 and superoxide dismutase. International Journal of General Medicine. 2022; 15:7319-28. [DOI:10.2147/IJGM.S367125] [PMID] [PMCID]
Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.Cancer Epidemiology, Biomarkers & Prevention. 2005; 14(12):2963-8. [DOI:10.1158/1055-9965.EPI-04-0768] [PMID]
Rapp JL, Alpert N, Flores RM, Taioli E. Serum cotinine levels and nicotine addiction potential of e-cigarettes: An NHANES analysis. Carcinogenesis. 2020; 41(10):1454-9. [DOI:10.1093/carcin/bgaa015] [PMID]
Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013; 15(1):158-66. [DOI: 10.1093/ntr/nts103] [PMID]
Strongin RM. E-cigarette chemistry and analytical detection. Annual Review of Analytical Chemistry. 2019; 12(1):23-39. [PMID] [PMCID]
Jain RB, Bernert JT. Effect of body mass index and total blood volume on serum cotinine levels among cigarette smokers: NHANES 1999-2008. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2010; 411(15-16) 1063-8. [DOI:10.1016/j.cca.2010.03.040] [PMID]
Kumboyono K, Chomsy IN, Firdaus DH, Setiawan M, Wihastuti TA. Protective cardiovascular benefits of exercise training as measured by circulating endothelial cells and high-density lipoprotein in adults. Journal of Taibah University Medical Sciences. 2022; 17(4) 701-6. [DOI:10.1016/j.jtumed.2021.12.003] [PMID] [PMCID]
- Abstract Viewed: 260 times
- pdf Downloaded: 281 times